Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults
This study has been completed.
Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Emory-Children's Center
Information provided by (Responsible Party):
Grace McComsey, University Hospital Case Medical Center
ClinicalTrials.gov Identifier:
NCT01410305
First received: August 4, 2011
Last updated: June 24, 2016
Last verified: June 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The relationship of Vitamin D levels in children and young adults to atherosclerosis.
| Condition |
|---|
|
Vitamin D Deficiency |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Vitamin D Metabolism Inflammation, and Cardiovascular Risk in HIV-infected Children and Young Adults |
Resource links provided by NLM:
Further study details as provided by University Hospitals Cleveland Medical Center:
Primary Outcome Measures:
- Vitamin D levels [ Time Frame: One time point at entry ] [ Designated as safety issue: No ]To perform a cross-sectional analysis of blood vitamin D status among the HIV-infected children and young adults to evaluated the point prevalence fo plasma 25(OH)D levels indicating vitamin D insufficiency, deficiency and severe deficiency, and to compare the prevalence to a matched uninfected healthy control group.
Biospecimen Retention: Samples With DNA
plasma, serum, PBMCs, urine
| Enrollment: | 290 |
| Study Start Date: | September 2011 |
| Study Completion Date: | December 2014 |
| Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
HIV+
HIV Positive children or young people between the ages of 8 and 25
|
|
HIV Negative
HIV Negative matched controls by age and race
|
Eligibility| Ages Eligible for Study: | 8 Years to 25 Years (Child, Adult) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Any HIV+ patient between the ages of 8 and 25 and matched HIV- controls matched by age and race.
Criteria
Inclusion Criteria - Documentation of HIV Infection Between ages of 8 and 25
- On stable ART for at least 12 weeks for the HIV+ patients
- Cumulative duration of ART for at least 48 weeks for HIV + patients
- Healthy child/young adult with age and race matched to HIV+ patient for the HIV- controls
- Absence of HIV based on medical and medication history
Exclusion Criteria:
- Taking > 800 IU of Vitamin D per day
- Parathyroid or Calcium disorders
- Acute illness and active inflammatory condition
- Chronic illnesses that include malignancy, diabetes, CAD
- Pregnancy and lactation
- Creatinine Clearance <50 ml/min
- Hgb < 9.0 g/dL
- AST and ALT > 2.5 upper limits of normal
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01410305
Please refer to this study by its ClinicalTrials.gov identifier: NCT01410305
Locations
| United States, Georgia | |
| Emory Chldren's Center | |
| Atlanta, Georgia, United States, 30308 | |
| United States, Ohio | |
| University Hospitals Case Medical Center, Case Western Reserve University | |
| Cleveland, Ohio, United States, 44106 | |
Sponsors and Collaborators
University Hospitals Cleveland Medical Center
Emory-Children's Center
Investigators
| Principal Investigator: | Grace McComsey, MD | University Hospitals Cleveland Medical Center |
| Principal Investigator: | Allison Ross Eckard, MD | Emory-Children's Center |
More Information
| Responsible Party: | Grace McComsey, Professor of Pediatrics and Medicine, University Hospital Case Medical Center |
| ClinicalTrials.gov Identifier: | NCT01410305 History of Changes |
| Other Study ID Numbers: | 1R01HD070490-01 |
| Study First Received: | August 4, 2011 |
| Last Updated: | June 24, 2016 |
| Health Authority: | United States: Institutional Review Board United States: Food and Drug Administration |
Keywords provided by University Hospitals Cleveland Medical Center:
|
Vitamin D Deficiency HIV+ Children HIV+ Young Adults |
Additional relevant MeSH terms:
|
Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Vitamins |
Vitamin D Ergocalciferols Micronutrients Growth Substances Physiological Effects of Drugs Bone Density Conservation Agents |
ClinicalTrials.gov processed this record on September 27, 2016